[Ischemic heart disease].
1Department of Cardiovascular Medicine, Graduate School of Medical Sciences, Kumamoto University.
Nihon Rinsho. Japanese Journal of Clinical Medicine
|April 8, 2009
Summary
Angiotensin converting enzyme (ACE) inhibitors are more effective than angiotensin II receptor antagonists (ARBs) in preventing ischemic heart disease events. Both therapies lower blood pressure, but ACE inhibitors show superior outcomes in clinical trials for heart health.
Area of Science:
- Cardiology
- Pharmacology
- Internal Medicine
Context:
- Antihypertensive therapy is recognized for reducing ischemic heart disease (IHD) risk.
- ACE inhibitors have demonstrated significant efficacy in primary and secondary prevention of cardiovascular events.
- Angiotensin II receptor antagonists (ARBs) offer an alternative mechanism by blocking the angiotensin II type 1 receptor.
Purpose:
- To compare the effectiveness of ACE inhibitors and ARBs in patients with ischemic heart disease.
- To evaluate the role of these drug classes beyond their antihypertensive properties in cardiovascular event prophylaxis.
Summary:
- Clinical trials indicate that while both ACE inhibitors and ARBs provide organ protection (vasculature, heart, brain, kidney), ACE inhibitors yield more favorable outcomes for patients with IHD.
- ACE inhibitors are proven effective for preventing initial and subsequent cardiovascular events.
- ARBs, despite their organ-protective actions, are less effective than ACE inhibitors in managing IHD.
Impact:
- Highlights the superior efficacy of ACE inhibitors over ARBs for ischemic heart disease management.
- Informs clinical practice regarding the selection of antihypertensive agents for cardiovascular event prevention.
- Suggests further research into the specific mechanisms underlying the differential effectiveness of ACE inhibitors and ARBs in IHD.
More Related Videos
10:21Evaluation of Hydration Status by Bioelectrical Impedance Vector Analysis in Patients with Ischemic Heart Disease Undergoing Exercise Stress Test
Published on: September 22, 2023
08:01Semi-Minimal Invasive Method to Induce Myocardial Infarction in Rats and the Assessment of Cardiac Function by an Isolated Working Heart System
Published on: June 11, 2020
Related Concept Videos
01:17Ischemic Heart Disease: Overview
Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...
01:15Ischemic Stroke l: Introduction
Ischemic stroke is an acute cerebrovascular condition in which blood flow to a brain region is suddenly interrupted, leading to tissue infarction. Neurons depend on continuous oxygen and glucose supply, so even brief reductions in perfusion cause energy failure, ionic imbalance, and irreversible injury. Ischemic strokes are classified into thrombotic and embolic types based on their underlying mechanisms.Thrombotic MechanismsThrombotic stroke develops when a clot forms within a cerebral artery.
01:15Ischemic Stroke ll: Pathophysiology
An ischemic stroke occurs when a cerebral blood vessel becomes obstructed, most often by a thrombus or embolus, interrupting the delivery of oxygen and glucose to brain tissue. Because neurons rely on continuous aerobic metabolism, energy failure begins within minutes of reduced perfusion. The region receiving the least blood flow becomes the infarct core, an area of irreversible cellular death. Surrounding this core lies the penumbra, a zone of hypoperfused but still viable tissue that is...
01:30Coronary Artery Disease III: Clinical Manifestations
Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
01:26Coronary Artery Disease II: Pathophysiology
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
01:27Heart Failure I: Introduction
Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...